Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10301385 Folate receptor 1 antibodies and immunoconjugates and uses thereof

Patent 10301385 was granted and assigned to Immunogen, Inc. on May, 2019 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Daniel Tavares0

Gillian Payne0

Lingyun Rui0

Olga Ab0

Viktor S. Goldmakher0

Date of Patent

May 28, 2019

0

Patent Application Number

155832810

Date Filed

May 1, 2017

0

Patent Citations

US Patent 10017578 Methods of treating cancer in a patient by administering anti-folate-receptor-1 (FOLR1) antibodies

Patent Citations Received

US Patent 11396543 Biparatopic FR-α antibodies and immunoconjugates

0

US Patent 11932701 Method for increasing the efficacy of cancer therapy by administering an anti-FOLR1 immunoconjugate

0

US Patent 11834498 Biparatopic FR-alpha antibodies and immunoconjugates

0

US Patent 10752683 Folate receptor 1 antibodies and immunoconjugates and uses thereof

Patent Primary Examiner

0

Patent abstract

Novel anti-cancer agents, including, but not limited to, antibodies and immunoconjugates, that bind to human folate receptor 1 are provided. Methods of using the agents, antibodies, or immunoconjugates, such as methods of inhibiting tumor growth are further provided.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10301385 Folate receptor 1 antibodies and immunoconjugates and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool